UNSPSC 51202206: Dexrazoxane

This classification denotes a metal chelator with the molecular formula C11H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 048L81261F, chemically known as 2,6-piperazinedione, 4,4-propylenedi-, (+)- but more generally known as dexrazoxane, which bears US NIH Compound Identifier 71384. European Medicines Agency schedules Dexrazoxane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07046MIG.

UNSPSC 51202206 Dexrazoxane, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The three most recent opportunities tagged to this code involve athletic training services for municipal fire and police departments, generic medical aid supplies for a fire rescue department, and a request for information about direct-to-manufacturer pharmacy contracting—none of which involve dexrazoxane or chemotherapy-supportive pharmaceuticals. The mismatch between the code's intended use (a cardioprotective agent used in oncology settings) and the actual goods or services being solicited suggests either tagging errors in the state and local systems or that dexrazoxane procurement does not move through standard RFP channels at the state and local level.

No relevant recent state and local solicitations for dexrazoxane or related oncology support pharmaceuticals appear in the current opportunities block. The City of Tucson, City of Tampa, and Texas Health and Human Services Commission have posted notices in this code family, but their actual procurement needs reflect general medical support rather than specialized pharmaceutical procurement. This code warrants continued monitoring, but it does not present active pursuit opportunities at present based on recent activity.